UCB PHARMA LTD

SL1 3WE (South East)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£60,000

Jul 16 - Jun 17

Feasibility study to determine whether a new generation of catalytic antibodies can be made that overcome existing limitations and are suitable for use in a range of clinical settings

Innovate UK award to UCB PHARMA LTD

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}